nodes	percent_of_prediction	percent_of_DWPC	metapath
Telbivudine—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0813	0.0813	CcSEcCtD
Telbivudine—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.063	0.063	CcSEcCtD
Telbivudine—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0441	0.0441	CcSEcCtD
Telbivudine—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0433	0.0433	CcSEcCtD
Telbivudine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.0349	0.0349	CcSEcCtD
Telbivudine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0344	0.0344	CcSEcCtD
Telbivudine—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.03	0.03	CcSEcCtD
Telbivudine—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.0268	0.0268	CcSEcCtD
Telbivudine—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0236	0.0236	CcSEcCtD
Telbivudine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.0221	0.0221	CcSEcCtD
Telbivudine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0205	0.0205	CcSEcCtD
Telbivudine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.0202	CcSEcCtD
Telbivudine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.0198	0.0198	CcSEcCtD
Telbivudine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0198	0.0198	CcSEcCtD
Telbivudine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0195	0.0195	CcSEcCtD
Telbivudine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0186	0.0186	CcSEcCtD
Telbivudine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.018	0.018	CcSEcCtD
Telbivudine—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.017	CcSEcCtD
Telbivudine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.0169	0.0169	CcSEcCtD
Telbivudine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0163	0.0163	CcSEcCtD
Telbivudine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0155	CcSEcCtD
Telbivudine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0154	CcSEcCtD
Telbivudine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0154	0.0154	CcSEcCtD
Telbivudine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0152	CcSEcCtD
Telbivudine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.014	0.014	CcSEcCtD
Telbivudine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0135	CcSEcCtD
Telbivudine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0132	CcSEcCtD
Telbivudine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.013	0.013	CcSEcCtD
Telbivudine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0125	CcSEcCtD
Telbivudine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0122	CcSEcCtD
Telbivudine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0118	CcSEcCtD
Telbivudine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Telbivudine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Telbivudine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Telbivudine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0114	CcSEcCtD
Telbivudine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0114	0.0114	CcSEcCtD
Telbivudine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0108	CcSEcCtD
Telbivudine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.0108	0.0108	CcSEcCtD
Telbivudine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0107	CcSEcCtD
Telbivudine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Telbivudine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00997	0.00997	CcSEcCtD
Telbivudine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0099	0.0099	CcSEcCtD
Telbivudine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0097	0.0097	CcSEcCtD
Telbivudine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00952	0.00952	CcSEcCtD
Telbivudine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0095	0.0095	CcSEcCtD
Telbivudine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00943	0.00943	CcSEcCtD
Telbivudine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00908	0.00908	CcSEcCtD
Telbivudine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00901	0.00901	CcSEcCtD
Telbivudine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.00871	CcSEcCtD
Telbivudine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.00871	CcSEcCtD
Telbivudine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.00791	CcSEcCtD
Telbivudine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0078	0.0078	CcSEcCtD
Telbivudine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00754	0.00754	CcSEcCtD
Telbivudine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00729	0.00729	CcSEcCtD
Telbivudine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00701	0.00701	CcSEcCtD
Telbivudine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.00695	CcSEcCtD
Telbivudine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00694	0.00694	CcSEcCtD
Telbivudine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00691	CcSEcCtD
Telbivudine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00655	0.00655	CcSEcCtD
